Related Experiment Video
Updated: Sep 22, 2025

Author Spotlight: Quantitative Detection of DNA Protein Crosslinks and Their Post-Translational Modifications
Published on: April 21, 2023
The interplay between DNA topoisomerase 2α post-translational modifications and drug resistance
Christophe Lotz1, Valérie Lamour1,2
1Integrative Structural Biology Department, IGBMC, Université de Strasbourg, CNRS UMR 7104, INSERM U1258, Illkirch 67404, France.
Abstract:
The type 2 DNA topoisomerases (Top2) are conserved enzymes and biomarkers for cell proliferation. The catalytic activities of the human isoform Top2α are essential for the regulation of DNA topology during DNA replication, transcription, and chromosome segregation. Top2α is a prominent target for anti-cancer drugs and is highly regulated by post-translational modifications (PTM). Despite an increasing number of proteomic studies, the extent of PTM in cancer cells and its importance in drug response remains largely uncharacterized. In this review, we highlight the different modifications affecting the human Top2α in healthy and cancer cells, taking advantage of the structure-function information accumulated in the past decades. We also overview the regulation of Top2α by PTM, the level of PTM in cancer cells, and the resistance to therapeutic compounds targeting the Top2 enzyme. Altogether, this review underlines the importance of future studies addressing more systematically the interplay between PTM and Top2 drug resistance.
Insights
Type 2 topoisomerases (Top2) are crucial for DNA regulation and cancer drug targets. This review explores how post-translational modifications (PTM) affect Top2α in cancer cells and influence drug resistance.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Type 2 DNA topoisomerases (Top2) are essential enzymes regulating DNA topology.
- Human Topoisomerase II alpha (Top2α) is vital for DNA replication, transcription, and chromosome segregation.
- Top2α is a key target for anti-cancer drugs and is regulated by post-translational modifications (PTM).
Purpose of the Study:
- To review the post-translational modifications (PTM) of human Top2α in healthy and cancer cells.
- To explore the regulation of Top2α by PTM and its role in cancer.
- To investigate the impact of PTM on resistance to Top2-targeting anti-cancer drugs.
Main Methods:
- Literature review synthesizing existing research on Top2α structure-function.
- Analysis of proteomic studies concerning PTM in cancer cells.
- Overview of Top2α regulation by PTM and its implications for drug resistance.
Main Results:
- Post-translational modifications (PTM) significantly affect Top2α function and regulation.
- The extent and impact of PTM on Top2α in cancer cells are not fully characterized.
- PTM plays a critical role in the development of resistance to Top2-targeting therapies.
Conclusions:
- Understanding Top2α PTM is crucial for developing effective cancer therapies.
- Further systematic studies are needed to elucidate the interplay between PTM and Top2 drug resistance.
- Targeting Top2α PTM may offer novel strategies for overcoming cancer drug resistance.
More Related Videos
10:13Simple and Fast Rolling Circle Amplification-Based Detection of Topoisomerase 1 Activity in Crude Biological Samples
Published on: December 2, 2022
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Related Concept Videos
DNA Topoisomerases
Types and Mechanism of action
Topoisomerases are divided into two main types. ...
Treatment Resistant Cancers
DNA Damage can Stall the Cell Cycle
Translesion DNA Polymerases
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
DNA Helicases